Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.19.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2019
Stockholders' Equity  
Schedule of Summary of restricted stock award activity

The following table summarizes restricted stock award activity for the nine months ended September 30, 2019:

 

 

 

 

 

 

 

 

 

 

Weighted Average 

 

 

 

 

Grant Date Fair

 

    

Number of Units

    

Value  

Nonvested at December 31, 2018

 

2,932,106

 

$

4.22

Granted

 

790,652

 

 

3.34

Forfeited

 

(21,000)

 

 

3.16

Vested

 

(299,607)

 

 

1.97

Nonvested at September 30, 2019

 

3,402,151

 

$

4.22

 

Schedule of Summary of stock option award activity

The following table summarizes stock option award activity for the nine months ended September 30, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average 

 

 

 

 

 

 

 

Remaining

 

 

 

 

Weighted Average 

 

 Contractual Life

 

    

Stock Options 

    

Exercise Price

    

(in years)

Outstanding as of December 31, 2018

 

60,000

 

$

5.43

 

8.09

Granted

 

50,000

 

 

3.25

 

 

Outstanding as of September 30, 2019

 

110,000

 

$

4.44

 

8.24

 

 

Schedule of Summary of warrant activities

A summary of warrant activities for the nine months ended September 30, 2019 is presented below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average 

 

 

 

 

 

 

 

Remaining

 

 

 

 

Weighted Average 

 

Contractual Life

 

    

Warrants 

    

Exercise Price 

    

(in years)

Outstanding as of December 31, 2018

 

4,280,972

 

$

6.69

 

2.33

Exercised

 

(73,525)

 

 

 —

 

 

Outstanding as of September 30, 2019

 

4,207,447

 

$

6.81

 

1.50

 

 

Schedule of Summary of stock-based compensation expense

The following table summarizes stock-based compensation expense for the three and nine months ended September 30, 2019 and 2018 ($ in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the three months ended September 30, 

 

For the nine months ended September 30, 

 

    

2019

    

2018

    

2019

    

2018

Research and development

 

$

179

 

$

642

 

$

559

 

$

930

General and administrative

 

 

654

 

 

485

 

 

1,885

 

 

1,406

Total stock-based compensation expense

 

$

833

 

$

1,127

 

$

2,444

 

$

2,336